Stockreport

Here's Why Agios Pharmaceuticals Crashed 23% Today [Globe and Mail, The (Toronto, Canada)]

Agios Pharmaceuticals, Inc.  (AGIO) 
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.agios.com/investor-overview
PDF Novo's etavopivat outperformed Agios' mitapavit in key sickle cell endpoints, Novo plans to file for FDA approval in late 2026, threatening Agios' market potential. S [Read more]